Literature DB >> 18404243

Utility values associated with osteoporotic fracture: a systematic review of the literature.

Mickaël Hiligsmann1, Olivier Ethgen, Florent Richy, Jean-Yves Reginster.   

Abstract

We reviewed studies that have estimated the impact of osteoporotic fracture on quality-adjusted life years (QALY) and to determine reference values for countries that would like to carry out cost-utility analyses but that do not have their own values. The computerized medical literature databases Medline and EMBASE were searched from January 1990 to December 2006. The search was carried out in two steps. The first step was to identify studies that related to quality of life in osteoporosis. As part of the second step, only the studies that translated quality of life into a utility value (one single value for health status ranging 0-1) and calculated a utility loss over a period of at least 1 year were selected. From the 152 studies identified in the first analysis, only 16 were retained after the second step. Ten studies investigated utility values for hip fractures, 11 for vertebral fractures, five for distal forearm fractures, and four for other osteoporotic fractures and fracture interactions. Utility values differed substantially between studies, partly due to the valuation technique used, the severity of fractures, and the sample size. This review suggests that there is no meaningful average value across different studies, different samples, different countries, or different instruments. Although we tried to determine the best available values, these values do not preclude the need for country-specific studies. Finally, we also make recommendations regarding the design and methodology for such studies.

Entities:  

Mesh:

Year:  2008        PMID: 18404243     DOI: 10.1007/s00223-008-9117-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  35 in total

1.  Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study.

Authors:  M S Cooper; A J Palmer; M J Seibel
Journal:  Osteoporos Int       Date:  2011-09-28       Impact factor: 4.507

2.  Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.

Authors:  T Imai; S Tanaka; K Kawakami; T Miyazaki; H Hagino; M Shiraki
Journal:  Osteoporos Int       Date:  2017-03-06       Impact factor: 4.507

3.  The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050.

Authors:  A Konnopka; N Jerusel; H-H König
Journal:  Osteoporos Int       Date:  2008-12-02       Impact factor: 4.507

4.  Cost-effectiveness of Virtual Bone Strength Testing in Osteoporosis Screening Programs for Postmenopausal Women in the United States.

Authors:  Christoph A Agten; Austin J Ramme; Stella Kang; Stephen Honig; Gregory Chang
Journal:  Radiology       Date:  2017-06-14       Impact factor: 11.105

5.  Cost-Effectiveness of Osteoporosis Screening Strategies for Men.

Authors:  Smita Nayak; Susan L Greenspan
Journal:  J Bone Miner Res       Date:  2016-02-10       Impact factor: 6.741

6.  Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.

Authors:  H Penton; M Hiligsmann; M Harrison; J-Y Reginster; A Boonen; N Bansback
Journal:  Osteoporos Int       Date:  2016-05-07       Impact factor: 4.507

7.  [Osteoporosis--which therapy is confirmed?].

Authors:  P M Jehle; J Pfeilschifter
Journal:  Internist (Berl)       Date:  2009-12       Impact factor: 0.743

8.  Vertebral fracture assessment (VFA) by lateral DXA scanning may be cost-effective when used as part of fracture liaison services or primary care screening.

Authors:  E M Clark; L Carter; V C Gould; L Morrison; J H Tobias
Journal:  Osteoporos Int       Date:  2013-11-29       Impact factor: 4.507

9.  Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.

Authors:  M Hiligsmann; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-04-07       Impact factor: 4.507

10.  [Osteoporosis--current diagnostics and therapy].

Authors:  Johannes Pfeilschifter
Journal:  Med Klin (Munich)       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.